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ABSTRACT Ca-calmodulin-dependent protein kinase II (CaMKII) was recently shown to alter Na1 channel gating and
recapitulate a human Na1 channel genetic mutation that causes an unusual combined arrhythmogenic phenotype in patients:
simultaneous long QT syndrome and Brugada syndrome. CaMKII is upregulated in heart failure where arrhythmias are
common, and CaMKII inhibition can reduce arrhythmias. Thus, CaMKII-dependent channel modulation may contribute to
acquired arrhythmic disease. We developed a Markovian Na1 channel model including CaMKII-dependent changes, and
incorporated it into a comprehensive myocyte action potential (AP) model with Na1 and Ca21 transport. CaMKII shifts Na1
current (INa) availability to more negative voltage, enhances intermediate inactivation, and slows recovery from inactivation (all
loss-of-function effects), but also enhances late noninactivating INa (gain of function). At slow heart rates, with long diastolic time
for INa recovery, late INa is the predominant effect, leading to AP prolongation (long QT syndrome). At fast heart rates, where
recovery time is limited and APs are shorter, there is little effect on AP duration, but reduced availability decreases INa, AP
upstroke velocity, and conduction (Brugada syndrome). CaMKII also increases cardiac Ca21 and K1 currents (ICa and Ito),
complicating CaMKII-dependent AP changes. Incorporating ICa and Ito effects individually prolongs and shortens AP duration.
Combining INa, ICa, and Ito effects results in shortening of AP duration with CaMKII. With transmural heterogeneity of Ito and Ito
downregulation in heart failure, CaMKII may accentuate dispersion of repolarization. This provides a useful initial framework
to consider pathways by which CaMKII may contribute to arrhythmogenesis.
INTRODUCTION
Cardiac sodium (Na1) channels control cardiac excitability
and the velocity of impulse propagation by initiating the
action potential (AP). Different disorders in heart excitability
have been related to derangement of the cardiac Na1 channel
(1). A number of inherited diseases associated with muta-
tions in SCN5A, the gene encoding the a-subunit of the
cardiac Na1 channel, have been discovered and linked to
long QT type 3 (LQT3) and Brugada (BrS) syndromes,
conduction diseases, and structural defects. Notably, muta-
tions showing overlapping phenotypes have been charac-
terized. A single human mutation (1795InsD) in SCN5A
is linked to simultaneous LQT3 and BrS features. This
1795InsD mutation in humans has been studied in expressed
Na1 channels (2). The mutant Na1 current (INa) exhibits
increased intermediate inactivation and slowed recovery
from inactivation, and the mutant Na1 channel availability is
shifted to more negative potentials, all of which would
reduce INa (loss of function) and could explain Brugada-like
symptoms in patients at faster heart rates. In addition, this
1795InsD mutation causes persistent INa, which fails to
completely inactivate during long-duration APs. The persis-
tent INa would produce a gain of function, and that could
contribute to AP prolongation and LQT syndrome. This
would be especially pronounced at slow heart rates where
INa recovery from inactivation may be more complete (even
with the mutation) and where the longer intrinsic AP du-
ration (APD) would increase the impact of the late INa.
Na1 channel gating may also be altered in acquired dis-
eases, e.g., drug-induced LQT syndrome, cardiac ischemia,
and heart failure (HF). In HF, altered Na1 channel regulation
could cause widespread acquired Na1 channel dysfunction
and arrhythmogenesis. For example, Ca-calmodulin-dependent
protein kinase II (CaMKII) is upregulated and also more
active in HF (3). Wagner et al. (4) recently showed that
CaMKII alters cardiac myocyte Na1 channel gating in a
manner very similar to the combined LQT/Brugada genetic
phenotype mentioned above (1795InsD). Adenovirus-medi-
ated (acute) and transgenic (chronic) overexpression of the
cytosolic d isoform (CaMKIIdc) shifted voltage dependence
of Na1 channel availability to more negative membrane
potentials, enhanced intermediate inactivation, and slowed
recovery from inactivation (and these effects were prevented
by CaMKII inhibitors). In addition, CaMKIIdc markedly
increased persistent (late) inward INa and intracellular [Na
1]
([Na1]i). From these alterations, one might expect less Na
1
channel availability at fast heart rates but more inward INa
during long APs at slow heart rates.
The increased levels of CaMKII in HF may target several
myocyte proteins (5). CaMKII phosphorylates Ca21 transport
proteins such as phospholamban (6), ryanodine receptors
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(7–9), and L-type Ca21 channels (8,10,11). In addition,
CaMKII can also modulate K1 channels (12–15). CaMKII is
known to mediate Ca21-dependent ICa facilitation (8,10,11),
and Kohlhaas et al. (8) showed that CaMKII overexpression
in rabbit myocytes increases peak ICa and slows inactiva-
tion (possibly related to ICa facilitation). CaMKII can also
modulate transient outward K1 current (Ito). Wagner et al.
(15) showed that upon CaMKII overexpression, the expres-
sion levels of Kv1.4 channels (responsible for the slow
component of Ito) are enhanced, as is the current recovery
from inactivation. Given the multiple CaMKII targets, it is
difﬁcult a priori to discern the relative effects of CaMKII
modulation of INa, ICa, and Ito on ventricular myocyte APs. In
this study, we simulate the CaMKII-induced alterations of
INa, ICa, and Ito (individually and collectively) on the rabbit
ventricular AP.
Mathematical models have been widely used to simulate
the voltage-dependent gating of ion channels. Composite
models of ion channels and excitation-contraction coupling
(ECC) allow investigation of the effects of altered Na1
channel kinetic properties on myocyte electrical activity
(16–18). Clancy and Rudy (16) showed that a theoretical AP
model could simulate the 1795InsD mutant current behavior
by including an extended formulation of their Markovian
Na1 channel structure that incorporates a bursting mode.
Here, we used a variation of this Markovian Na1 channel
model to simulate the CaMKIIdc effects on INa reported by
Wagner et al. (4) and we incorporate this into a compre-
hensive AP and ECC model of rabbit ventricular myocytes
(19). We also incorporated CaMKII-dependent effects on
ICa and Ito in rabbit ventricular myocytes to distinguish the
independent and combined effects of these CaMKII targets
on APD.
METHODS
Na1 current model simulation
The Markov model structure (Fig. 1) implemented in this study is based on
that proposed by Clancy and Rudy (16,17). It contains two modes of gating,
a background mode and a burst mode. The background mode reﬂects the
normal sequence of activation and inactivation that most channels undergo
upon depolarization and contributes predominantly to the large transient
component of INa. The burst mode reﬂects a small population of channels
that transiently fail to inactivate during the AP plateau and results in a
sustained inward current. The background mode includes the nine states in
the upper two rows, consisting of three closed states (C3, C2, and C1), a
conducting open state (O), a fast inactivation state (IF), and two intermediate
inactivation states (IM1 and IM2) that are required to reproduce the complex
fast and slow recovery features of INa inactivation. The lower four states in
Fig. 1 correspond to the burst or late mode (preﬁx L), in which inactivation
does not occur. Voltage (Vm)-independent transition rates between upper and
lower states represent a probability of transition between the two modes of
gating.
Table 1 shows the expressions of the transition rates between the Markov
model states. The corresponding parameters were identiﬁed by a ﬁtting
procedure to simulate the electrophysiological characterization of cardiac INa
in bGal and in CaMKIIdc-overexpressing rabbit myocytes reported by
Wagner et al. (4). The following voltage-clamp protocols were simulated for
parameter identiﬁcation: activation, steady-state inactivation, intermediate
inactivation, recovery from inactivation, and long-depolarization voltage
step to assess late INa. The model results for each protocol were compared
with experimental data. The transition rate parameters that maximally
inﬂuence each voltage-clamp protocol were identiﬁed with an automatic
procedure. Namely, the ratio a8/b8 was modiﬁed to reproduce the
experimental data accounting for late INa; a5/b5 was tuned to correctly
simulate the channel availability curve; a6, b6 and a7, b7 were adjusted to
represent the observed characteristics of intermediate inactivation and
recovery from inactivation. The Nelder-Mead simplex direct algorithm was
used to ﬁnd the parameter values minimizing the sum of the least-square
errors between model predictions and experimental data for each protocol.
The values proposed by Clancy and Rudy (16) were chosen as initial guesses
in the minimization procedure to identify the transition rate parameters that
allowed the best ﬁtting of our bGal data. The identiﬁed bGal set in Table 2
was subsequently used as an initial guess to identify the CaMKIIdc channel
parameters. The parameters that inﬂuence more than one protocol were then
manually tuned to optimize ﬁtting to all the experimental data. A full list of
the parameters is given in Table 2. Matlab 7 and Simulink (The MathWorks,
Natick, MA) were used for all numerical computations.
L-type Ca21 current simulation
The L-type Ca21 current formulation of Shannon et al. (19) was modiﬁed to
reproduce the effects of CaMKII (8) by increasing the channel maximal
conductance by 10% and mimicking Ca21-dependent facilitation with an
additional term that makes the Ca21-dependent inactivation less complete.
In bGal-overexpressing cardiomyocytes, Ca21-dependent inactivation
(local Kd(Ca) ¼ 7 mM) is modeled by using the variable fCa, in which
dynamic changes are described as
fCa ¼ 1 fCaB
dfCaB
dt
¼ 1:7½Ca21 cð1 fCaBÞ  0:0119fCaB;
where [Ca21]c is the [Ca
21] in the actual compartment (either junctional or
subsarcolemmal space, in mM).









Transient outward K1 current simulation
The formulations of the slow and fast component of Ito were adapted from
Bassani et al. (20) to account for the increased expression levels of Kv1.4
channels and for the enhanced recovery from inactivation in CaMKII-
overexpressing rabbit myocytes (15). To this purpose, maximal conductance
of the slow component Gto,slow was increased by 50% in the CaMKII model
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Values of Py, PR1, and PR2 are (in ms) 182, 8085, and 131, respectively, for
bGal and 15, 3600, and 500, respectively, for CaMKII-overexpressing
cardiomyocytes.
Action potential simulation
The ventricular AP was simulated using the Chicago model of rabbit
ventricular myocyte (19), which includes both a cleft space (between
sarcoplasmic reticulum (SR) and sarcolemmal membrane) and a separate
subsarcolemmal compartment (where sarcolemmal ion channels and
transporters sense higher [Ca21]i than in the bulk cytosol). The model was
implemented in Matlab 7 (The MathWorks, Natick, MA). The model was
adjusted to correctly describe the ratio between slow and fast components of
Ito to reproduce the experimental APD adaptation to the pacing rate observed
in rabbit myocytes (21). For this purpose, the conductances of Ito,fast and
Ito,slow were set to 0.02 and 0.06 mS/mF, respectively.
The INa model was replaced with the above Markov model. Maximal
conductance GNa at 37C was calculated as 23 mS/mF for both bGal and
CaMKII (Q10 ¼ 1.5 for Na1 channel conductance (22)). The kinetic rates
were normalized to 37C with a Q10 of 2.1 (22). ICa was similarly scaled up
to 37C, using our previous measurements in rabbit ventricular myocytes
at 25C and 35C (23). Total Ito density was lower in rabbit ventricular
myocytes expressing bGal after 24–36 h in culture (15), compared to freshly
isolated myocytes (20). To better reﬂect the physiological situation for AP
simulations, we used fresh myocyte Ito amplitudes (Ito,fast and Ito,slow) for
control and relative changes caused by CaMKII versus bGal overexpression
to simulate the CaMKII case. Pacing was simulated by a current pulse train
(pulses of 5 ms in duration) of 9.5 A/F in amplitude with different
frequencies (0.1, 0.25, 0.5, 1, 2, and 3 Hz). A variable order solver based on
the numerical differentiation formulas was used to numerically solve the
model equations (ode15s) (24). The stimulation was maintained until a
steady AP was reached (typically ;100 s).
FIGURE 1 Markov model of the cardiac
Na1 channel. The channel model contains
background (upper nine states) and burst
(lower four states) gating modes. The burst
mode reﬂects a population of channels that
transiently fail to inactivate and accounts for a
sustained inward current (or late current).
TABLE 1 Transition rate expressions (ms1)
Transition rates
a1 ¼ (P1a1/(P2a1 exp(Vm/17) 1 0.20 exp(Vm/150)))
a2 ¼ (P1a1/(P2a1 exp(Vm/15) 1 0.23 exp(Vm/150)))
a3 ¼ (P1a1/(P2a1 exp(Vm/12) 1 0.25 exp(Vm/150)))
b1 ¼ P1b1 exp(Vm/P2b1)
b2 ¼ P1b2 exp( (Vm  P2b2)/(P2b1))
b3 ¼ (P1b3 exp( (Vm  P2b3)/(P2b1)))
a5 ¼ P1a5 exp(Vm/P2a5)
b5 ¼ (P1b5 1 P2b5 Vm)
a4 ¼ (P1a4 exp(Vm/P2a4))
b4 ¼ (a3 a4 a5)/(b3 b5)
a6 ¼ a4/P1a6
b6 ¼ P1b6 exp(Vm/P2b6)
a7 ¼ (P1a7 exp(Vm/P2a7))
b7 ¼ P1b7 exp(Vm/P2b7)
a8 ¼ P1a8
b8 ¼ P1b8
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RESULTS
Na1 current simulation
Steady-state inactivation and activation
Fig. 2 shows experimental data (7) and simulations, which
conﬁrm the adequacy of the Na1 channel Markovian model.
Table 3 shows sources of experimental data used for
validation of the simulations here. To assess the voltage
dependence of steady-state inactivation (or availability), INa
was measured during test pulses to 20 mV (20 ms) after
500-ms prepulses from 140 mV to various Vm (with 10-mV
increments). As in the experimental data, CaMKIIdc over-
expression shifts inactivation to more negative potentials with
respect to bGal (Fig. 2 A).
Steady-state activation was not altered by CaMKIIdc in
the experimental data (4). This was assessed by 40-ms
depolarizations from a holding potential of 140 mV to
80/160 mV (with 10-mV increments). Relative conduc-
tance was taken by dividing peak INa by the driving force
(Vm  ENa). The resulting conductance was normalized to
the maximal chord conductance. As in the experimental data,
simulated CaMKIIdc overexpression does not affect INa
activation with respect to bGal (Fig. 2 B; note that bGal and
CaMKIIdc traces are superimposed).
Recovery from inactivation and intermediate inactivation
Recovery from inactivation was investigated using a 1000-
ms depolarization to –20 mV, which initiates fast and inter-
mediate inactivation (P1), followed by a recovery interval of
variable duration and a subsequent test pulse (P2). CaMKIIdc
slows recovery from inactivation in our simulations, as well
as in the experimental results (Fig. 2 C). Accumulation of
intermediate inactivation was assessed using depolarizations
of variable duration (P1) followed by a 20-ms recovery
period at 140 mV (which allows channel recovery from
fast inactivation). Na1 channels that have undergone in-
termediate inactivation would still be largely unavailable,
causing a reduction in INa at the subsequent test pulse P2
to 20 mV. In the computer simulations, as in the experi-
mental recordings, intermediate inactivation is enhanced by
CaMKIIdc (Fig. 2 D).
FIGURE 2 Experimental (squares) and sim-
ulated (solid lines) voltage-clamp protocols for
bGal- (black) and CaMKII-modulated (gray)
Na1 channels (data at 140 mM external Na1
concentration). (A) Steady-state inactivation.
CaMKIIdc overexpression shifts the availabil-
ity curve toward negative potentials. (B) Acti-
vation. Na1 channel activation is not affected
by CaMKIIdc overexpression (traces are super-
imposed). (C and D) CaMKIIdc slows the
recovery from inactivation (C) and enhances
the intermediate inactivation (D). (E) Late INa is
enhanced by CaMKIIdc overexpression. Sim-
ulated traces are shown at left, and bar graphs
of simulated and experimental normalized
current integrals at right. (F) Fast and slow
time constants of INa decay. Acute CaMKIIdc
overexpression slows the late component of
fast INa inactivation. Experimental data are from
Wagner et al. (15).
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Late current
CaMKIIdc enhances late INa. Currents were elicited by
1000-ms depolarizations to 20 mV (from 140 mV), and
normalized to peak INa. The current integral was calculated
between 50 and 500 ms (Fig. 2 E) and plotted relative to
the INa integral if no inactivation had occurred (i.e., peak
current 3 450 ms). As shown in Fig. 2 E, compared to con-
trol, simulated CaMKIIdc overexpression resulted in a larger
late INa. These results ﬁt the experimental data (4) shown for
comparison in Fig. 2 E.
Fast inactivation
CaMKIIdc slows fast Na1 channel inactivation in rabbit
CaMKIIdc myocytes compared to bGal (Fig. 2 F). The
Na1 current decay (ﬁrst 50 ms) was ﬁtted with a double
exponential function. Fits (dotted lines) to the simulated
traces (solid lines) and corresponding parameters t1 and t2
(ms) are shown in black (bGal) and gray (CaMKIIdc). The
deceleration of current decay was most prominent in the
late component (at right in Fig. 2 F), so that t2 was greater
compared to control (7.8 vs. 5.6 ms), whereas t1 appeared
to be unchanged (1.3 ms), in agreement with Wagner et al.
(4).
CaMKII-dependent Na1 current alterations on
AP and [Na1]i
The simulations of the effect of the CaMKII-dependent Na1
channel kinetic alterations on ventricular AP are shown in
Fig. 3 for three pacing rates (3, 1, and 0.25 Hz). Na1 channel
modulation did not change overall AP morphology with
respect to bGal. The bGal AP (black line) exhibits a
characteristic AP shape and its duration (185, 288, and 354
ms) shows the typical rabbit APD dependence on pacing
frequency (Fig. 3 E, black symbols). CaMKII APs (gray line)
exhibit distinctive rate-dependent durations (Fig. 3 E, gray
symbols). At fast rates (3 Hz), the CaMKII AP is grossly
superimposable on the control AP (Fig. 3 A, APD90 ¼ 188
ms). However, the short recovery interval limits Na1
channel recovery in the CaMKII case, resulting in reduced
INa amplitude, slight decrease in AP peak, and reduced AP
upstroke velocity (maximum dVm/dt; see Fig. 3 A, inset). At
low frequencies, AP upstroke velocity is reduced by ;10%
by the CaMKII effect, but this decrease becomes more
prominent at higher frequencies (Fig. 3 D). This Na1
channel loss of function would reduce AP rate of rise and
conduction velocity, especially at fast heart rates. At lower
rates (Fig. 3, B and C), APD is signiﬁcantly prolonged,
TABLE 3 CaMKII overexpression data
Figure Measure Source Experiment
Fig. 2 INa Wagner et al. (4) Rabbit myocyte, 22C, ruptured patch clamp
Fig. 4 [Na1]i Wagner et al. (4) Rabbit myocyte, 22C, ruptured patch clamp
Fig. 5 ICa Kohlhaas et al. (8) Rabbit myocyte, 22C, ruptured patch clamp
Fig. 6 Ito Wagner et al. (15) Rabbit myocyte, 22C, ruptured patch clamp
Fig. 8 AP Wagner et al. (15) Rabbit myocyte, 22C, ruptured patch clamp
FIGURE 3 CaMKII effects on Na1 channel gating
affect the AP in a rate-dependent manner. (A–C) Simula-
tions show that at slower heart rates the enhanced late
INa prolongs the AP (B and C); this effect is completely
blunted at faster rates (A), where the reduced channel
availability slows down the AP upstroke (A, inset). (D)
The upstroke velocity (dVm/dt) is reduced upon CaMKII
overexpression in a rate-dependent fashion: the faster the
pacing rate, the more signiﬁcant the decrease in maximum
dVm/dt. (E) Quantitative summary of the APD90 depen-
dence on the pacing rate.
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especially at the slowest rates (APD90 ¼ 344 ms at 1 Hz and
APD90 ¼ 553 ms at 0.25 Hz). At these low frequencies,
CaMKII-dependent impaired fast inactivation and enhanced
late INa outweigh the slowed recovery from inactivation
(because the long diastolic interval allows more complete
Na1 channel recovery). Thus, CaMKIIdc-induced AP pro-
longation is especially apparent at slow heart rates, and is due
to the presence of a larger inward late INa during phases 2 and
3 of the AP.
Intracellular [Na1] is slightly increased at low pacing fre-
quencies in CaMKII simulations as a result of the enhanced
late INa during the AP plateau (Fig. 4 right). However, at
faster rates, where APD is short and late INa is very small,
[Na1]i does not change signiﬁcantly between bGal and
CaMKII. The experimental ﬁndings of Wagner et al. (4), on
the other hand, show a markedly higher [Na1]i in CaMKII-
overexpressing cardiac myocytes at all frequencies (Fig. 4
left). However, if we normalize the measured [Na1]i to the
value at 2 Hz (Fig. 4 left, dotted line), we again see that the
increase in [Na1]i is larger at lower frequency. The higher
overall [Na1]i seen in the experimental data suggests that our
simulation fails to account for an overall gain in [Na1]i in the
myocytes with more active CaMKII. Possibly, CaMKII
modulates background Na1 inﬂux or efﬂux by another
mechanism.
Ca21 current simulation
In both acute and chronic CaMKIIdc overexpression, L-type
Ca21 current was signiﬁcantly increased in amplitude and
exhibited some slowing of inactivation (7,8). Data from
rabbit myocytes acutely overexpressing CaMKIIdc versus
LacZ rabbit myocytes are shown in Fig. 5, A and B. The
simulated ICa under voltage clamp produces an increase in
ICa amplitude, slowing of inactivation, and unaltered voltage
dependence (Fig. 5, C and D) similar to the experimental
data. The larger ICa amplitude and slower inactivation would
be expected to increase APD.
K1 current simulation
Acute CaMKIIdc overexpression in rabbit ventricular my-
ocytes increases Ito amplitude and speeds recovery from
inactivation, and these effects are primarily attributable to
alterations in the slowly recovering fraction of Ito (Ito,slow
versus Ito,fast (15)). Fig. 6 shows the agreement between
experimental and simulated effects of CaMKIIdc over-
expression on Ito. Representative traces are shown for
comparison between the recordings and the simulated
currents upon voltage-clamp stimulation (Fig. 6 G). The
Vm dependence of Ito (Fig. 6, left and middle columns) shows
an increase in total Ito in both the experiments (Fig. 6 A) and
simulations (Fig. 6 D). Ito,slow amplitude was also larger in
both experiments and simulations (Fig. 6, B and E), whereas
no signiﬁcant differences between experiments and simula-
tions are evident for Ito,fast (Fig. 6, C and F). Ito,total recovery
from inactivation was faster in CaMKIIdc-overexpressing
rabbit myocytes (Fig. 6 H, symbols) as well as in silico (Fig.
6 H, lines). The combined CaMKII-dependent increase of
Ito amplitude and faster Ito,slow recovery would tend to shorten
APD with CaMKII activation (i.e., opposite to that caused by
the INa and ICa effects discussed above).
Impact of Na1, Ca21, and K1 current alterations
on AP and [Na1]i
In simulations (compared with experiments), it is possible to
test the impact of each individual CaMKIIdc current effect
on the rabbit ventricular AP, individually or collectively. Fig.
7 A shows the control (bGal) AP morphology and duration
(black solid line) at 1 Hz and Fig. 7 B shows APD
dependence on pacing rate (Fig. 7 B, black circles). As in
Fig. 3, the effects of CaMKII on INa alone tend to prolong the
AP (Fig. 7 A, dashed line) especially at slow heart rates, but
less so at 2 Hz pacing (Fig. 7 B, diamonds). The CaMKII-
induced gain of function of ICa also prolongs APD at 1 Hz
(Fig. 7 A, dotted line) and other frequencies, though less so
than the INa change (Fig. 7 B). CaMKII-dependent Ito
modulation alone markedly shortens the AP, and ﬂattens the
frequency dependence of APD (Fig. 7 A and B, dash-dotted
curve).
When all three CaMKII target channels are considered
(INa, ICa, and Ito), the net effect is that APD is reduced
compared to bGal (Fig. 7, A and B, gray line and solid
circles). The large effect of Ito enhancement to shorten APD
appears to be dominant over the smaller effects on INa and ICa
which prolong APD. However, the individual ion channel
effects on APD modulation seem roughly additive. Fig. 8
shows experimental APD results in rabbit ventricular
FIGURE 4 Experimental (left) and simulated (right) CaMKII effects on
[Na1]i induced by INa alterations. (Left) The dotted line shows the shifted
experimental CaMKII data to equalize [Na1]i at 2 Hz. (Right) The dashed
line represents the [Na1]i at different frequencies when INa, ICa, and Ito
alterations due to CaMKII are incorporated into the model.
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myocytes overexpressing CaMKIIdc: at left are the results
from the study of Wagner et al. (15) and at right are those
from the simulations presented in this study. CaMKIIdc
overexpression shortens the rabbit ventricular APD. Over the
full range of experimental measurements (0.25–2 Hz), APD
was reduced by 40–50 ms in the CaMKII case compared
to bGal (Fig. 8, B and D). At 0.1 Hz, the model predicts APs
of similar duration for bGal and CaMKII (Fig. 8 D). It is
FIGURE 5 CaMKII effects on ICa. (Left) Experimental
(A) and simulated (C) traces recorded upon a depolariza-
tion pulse. (Right) Experimental (B) and simulated (D)
I/V relations. ICa is signiﬁcantly increased in CaMKIIdc
compared to control (LacZ). Inactivation is slowed by
CaMKIIdc. Experimental data (upper panels) are from
Kohlhaas et al. (8).
FIGURE 6 CaMKII effects on Ito. Experi-
mental (left) and simulated (middle) I/V rela-
tions for total (A andD), slow (B and E), and fast
(C and F) Ito. CaMKIIdc-mediated increase of
the total current (solid symbols) is mainly due to
CaMKIIdc effects on the slow component. (G)
Representative current traces during voltage-
clamp activation protocol for experimental (up-
per) and simulated (lower) CaMKII-mediated Ito.
(H) Recovery from inactivation was investigated
using a 500-ms depolarization pulse (from 80
mV holding potential to 150 mV) followed by
recovery intervals of increasing duration and a
subsequent test pulse. Recovery from inactiva-
tion was signiﬁcantly increased by CaMKIIdc.
Symbols represent experimental data, and lines
indicate simulation results for bGal (black) and
CaMKII (gray). Data are fromWagner et al. (15).
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possible that at extremely low frequencies the more prom-
inent late INa counteracts the enhancement of Ito with almost
no changes in the APD.
[Na1]i was also assessed during AP simulations. When ICa
and Ito effects were added to the INa effect, there was slightly
more CaMKII-induced rise in [Na1]i at higher frequency
(Fig. 4, right, dashed line). This might be due to higher Na1
inﬂux via Na1/Ca21 exchange in this situation. However,
the rise in [Na1]i still does not reach the CaMKII-dependent
[Na1]i rise seen in the experimental data (Fig. 4, left).
APD sensitivity to the late Na1 current
We investigated the impact of different amounts of late INa
on the APD. To this purpose, the value of the transition rate
between background and bursting modes of INa (a8) was
varied. For bGal, a range of late INa integrals (normalized to
peak INa if no inactivation had occurred) from 0.02 to 0.2%
was explored. Accordingly, late currents ranging from 0.17%
to 0.35% were reproduced for CaMKIIdc (to keep the 0.15%
differential amount of late current according to experimental
data). The results of this sensitivity analysis (Fig. 9) show
that the noninactivating Na1 current has a signiﬁcant effect
on the AP, and this effect is more pronounced at slower
pacing rates (compare 0.5 and 1 Hz). Moreover, such anal-
ysis qualitatively conﬁrms our results, since in the entire
range explored, CaMKII shortens the AP with respect to
bGal, independent of the actual amount of sustained INa.
APD changes with different Ito levels
Differences in the expression pattern of the channels
responsible for Ito,fast and Ito,slow in different regions of the
heart produce marked differences in current density and
contribute to regional variations in AP duration (25). In
addition, downregulation of Ito is a central and consistent
electrophysiological change in cardiac diseases (e.g., HF)
(26). Thus, different levels of Ito density (both fast and slow)
were simulated (Fig. 10). The simulation of CaMKII has
different impacts depending on Ito density. That is, when Ito
is fully expressed (Ito 100% (Fig. 8 C and Fig. 10, A and D)),
CaMKII shortens the AP, whereas in cells expressing 75%
or 90% Ito reduction, the effect of CaMKII-induced Ito
enhancement is limited (Fig. 10, B and C). In conditions
where Ito expression is ,60% (Fig. 10 D), net AP prolon-
gation occurs due to the INa and ICa effects (which then
outweigh the Ito effect).
DISCUSSION
In this study, we used an in silico approach to investigate
CaMKIIdc effects on cardiac myocyte ionic currents and
APs in a comprehensive computer model of ECC (19). A
motivating factor was our recent report (4) that CaMKII
associates with and phosphorylates the cardiac Na1 channel
and produces INa gating changes that strikingly resemble
those in a human genetic mutation in Nav1.5 (1795InsD) that
is linked with simultaneous arrhythmogenic LQT3 and
Brugada syndrome (2). In addition, CaMKII expression is
upregulated and more active in HF (3,27,28) and arrhythmias
are a major cause of death in HF. There are also reports of
enhanced late INa in HF (29). Thus, increased CaMKII-
dependent INa modulation in HF may be an acquired
arrhythmogenic Na1 channel defect that could affect
millions of people with HF (as compared with the relatively
small number of individuals affected by the mechanistically
informative genetic Na1 channel mutations). Along these
lines, overexpression of CaMKIIdc in transgenic mice leads
to a lethal phenotype characterized by HF (30) and increased
propensity to ventricular arrhythmias (4). Transgenic or
pharmacologic CaMKII inhibition has also been shown to be
protective against maladaptive remodeling from chronic
b-adrenergic receptor stimulation, myocardial infarction
(31), and arrhythmias (32). Thus, CaMKII may be a viable
FIGURE 7 Simulated APs at 1-Hz pacing rate (A) and APD-frequency
relations (B) in bGal and CaMKIIdc-overexpressing cardiac myocytes. The
separate effects of each CaMKII-induced current alteration, as well as their
combined impact, have been considered. CaMKII alteration of INa prolongs
the AP at slow heart rate, with no effects at a 2-Hz pacing. The APD is
reduced by Ito and increased by ICa at all frequencies. The predicted overall
effect of CaMKII is AP shortening.
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therapeutic target in the treatment of common forms of
cardiac disease, and understanding how CaMKII alters ionic
currents and APs is important to better understand arrhyth-
mias that occur in conditions of CaMKII upregulation.
We focused initially on CaMKII-dependent modulation of
INa (4), but we have extended the rabbit ventricular myocyte
model to incorporate other channels modulated by CaMKII
in heart, ICa (8) and Ito (15). This sort of computational
approach has proven valuable to integrate information
obtained at the molecular level to the whole cell and to the
clinical phenotype in a number of inherited (16–18,33) and
acquired (34–36) cardiac diseases.
Na1 channel model
A Markov model of INa was identiﬁed to simulate INa
measured using whole-cell patch clamp in bGal versus
CaMKIIdc-overexpressing rabbit cardiomyocytes (4). This
model structure has been used successfully to simulate
several INa features (16–18,33). Clancy and Rudy (16) used
a nine-state model (only the background mode) for the
wild-type Na1 channel. To account for long-lasting bursts
experimentally observed in mutant Na1 channels they
introduced an additional mode of gating (burst mode) with
a second (long-lasting and noninactivating) open state (17).
Thus, the burst layer, thought to be responsible for a whole-
cell persistent current, was incorporated into both our bGal
and CaMKIIdc Na1 channel models. The resulting model
satisfactorily reproduces the characteristics of CaMKIIdc-
modulated INa in rabbit ventricular myocytes (4) and seems
suitable to analyze the effects of CaMKIIdc at the AP level.
Impact of Na1 current alterations on AP and [Na1]i
CaMKIIdc enhances intermediate inactivation and reduces
availability, at the same time impairing fast inactivation and
FIGURE 8 Experimental (A and B) and simulated (C
and D) APs and APD-frequency relations in bGal and
CaMKIIdc-overexpressing cardiac myocytes. Experimen-
tal data are from Wagner et al. (15). CaMKII shortens the
AP in the entire range of pacing rates. At 0.1 Hz, where
no experimental data are available, the difference between
bGal and CaMKIIdc APs is negligible.
FIGURE 9 APD90 sensitivity to the late Na
1 current amplitude. APs were
simulated by varying the amount of late Na1 current in a range between
0.02% and 0.2% of the peak current in bGal (open symbols) and between
0.17% and 0.35% in CaMKII (solid symbols), thus keeping constant the
differential current amplitude. APD changes signiﬁcantly with the late
current amplitude, and the sensitivity increases with the lowering of the
pacing frequency (compare 0.5 and 1 Hz). Note that the results of AP
shortening upon CaMKII overexpression are conﬁrmed for any value of late
Na1 current amplitudes in the explored range.
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enhancing persistent INa. These divergent alterations of INa
function cause a paradoxical phenotypic overlap of LQT3
(where INa inactivation is slowed or incomplete) and
Brugada syndrome (where available INa is reduced), both
thought to underlie arrhythmias. Indeed, the altered Na1
channel phenotype caused by CaMKIIdc is very similar both
qualitatively and quantitatively to that caused by 1795InsD
mutation in human Nav1.5, which is linked with simulta-
neous LQT3 and Brugada syndrome features (2).
At faster heart rates, CaMKII causes Na1 channel
accumulation in intermediate inactivation, with slow recov-
ery therefrom, and reduces steady-state availability. The
result is a loss of INa function, reduced rate of AP rise, and,
consequently, slowed propagation velocity, consistent with a
BrS phenotype at fast heart rate. At slow heart rates where
the diastolic interval is longer, there is little loss of Na1
channel availability (longer recovery time), and the intrin-
sically longer APD is further prolonged by sustained or late
INa. This results in accentuated APD prolongation at slow
heart rates (Fig. 3, B, C, and E) and an LQT3 phenotype.
It is possible that increased CaMKIIdc activity in HF may
alter Na1 channel gating, contributing to arrhythmogenesis.
Indeed, noninactivating late INa is increased in human HF
and failing canine hearts (29), and this could contribute to the
prolonged APD characteristic of HF.
A higher sustained INa in HF due to CaMKIIdc could
contribute to the elevated [Na1]i observed in HF (37).
However, the simulations here show that the INa gating
changes that prolong APD are insufﬁcient to explain the
elevated [Na1]i in either HF or CaMKII-overexpressing
rabbit myocytes. Despa et al. (38) found that the elevated
[Na1]i in HF was due to increased tetrodotoxin-sensitive
diastolic inﬂux. The fact that CaMKII overexpression
produced a [Na1]i increase (4) similar to that seen in HF
(38), where CaMKII is upregulated (3), suggests an untested
hypothesis that CaMKII might enhance diastolic tetrodo-
toxin-sensitive Na1 inﬂux in both situations.
The slight additional rise in [Na1]i at higher frequency
when ICa and Ito effects of CaMKII were considered (versus
INa alone), could be due to the close interplay between Na
1
and Ca21 regulation in myocytes. The higher ICa and SR
Ca21 release would increase Na1 inﬂux via a Na1/Ca21 ex-
changer (which is the largest normal pathway for Na1 inﬂux
in myocytes).
CaMKII has multiple targets that may alter AP
Although Na1 channel alterations can result in gain or loss
of function, depending on the pacing frequency, CaMKII
modulation of ICa and Ito produced only gain of function at
all pacing rates. Enhanced ICa prolonged APD, whereas Ito
gain of function dramatically shortened APD (Fig. 7). When
considering the effects of CaMKII on INa, ICa, and Ito
together, APD was shortened, indicating the stronger impact
of the enhanced repolarizing Ito (compared to the combined
depolarizing contributions of ICa and INa). It is noteworthy
that this balance is shifted toward a net repolarizing current
in a wider range of late INa, as demonstrated by the sensi-
tivity analysis in Fig. 9.
We also included CaMKII-dependent alterations to in-
crease the [Ca21]i afﬁnity of the SR Ca-ATPase (simulating
phospholamban phosphorylation) and sensitization of the SR
Ca21 release channel (not shown) using parameters similar
to those used by Shannon et al. (39). Although this altered
Ca21 transients and APD characteristics slightly, the APD
shifts reported here were not qualitatively altered. Thus,
FIGURE 10 Simulated APs at 1 Hz in bGal and CaMKIIdc-overexpressing
cardiac myocytes in the presence of (A) 100%, (B) 25%, and (C) 10% Ito. (D)
Ratio of CaMKII to bGal APDs for different levels of Ito. When Ito is fully
expressed (A, epi), CaMKII shortens the AP, whereas the AP is prolonged due
to Ito downregulation (current expression ,60% (D), e.g., endo (B and C)).
This could amplify transmural dispersion of repolarization (endo-epi: 66 and
78 ms for bGal versus 152 and 183 ms for CaMKII), which may predispose
cells to reentry phenomena.
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these effects do not modify our main conclusions about INa,
ICa, and Ito effects.
The CaMKII-induced enhancement of Ito would tend to
prevent the LQT3 effect of late INa and ICa enhancement, and
it would not ameliorate the BrS phenotype at fast heart rates.
Indeed, the greater Ito might slightly further snub the latter
part of the AP rise and the AP peak, accentuating the BrS
phenotype. On the other hand, the concerted effect of
CaMKII on Ito (with INa and ICa) may be an orchestrated
response to limit APD prolongation when CaMKII is
physiologically activated. In pathophysiological conditions
like HF, this situation may differ. In HF there is typically a
strong downregulation of Ito (26), and this would limit the
ability of enhanced Ito to offset the APD prolongation
resulting from INa and ICa effects (Fig. 10). The lower
amplitude of SR Ca21 release in HF would also limit the
extent of Ca-dependent inactivation of ICa, which would also
tend to prolong APD. These effects could make the HF
patient (in whom APD is already long) more prone to this
sort of acquired LQT3 and its arrhythmogenic consequences.
The AP-ECC model implemented here (19) is for a
generic rabbit ventricular myocyte, without distinction for
regional differences in channel density within the normal
ventricular wall (40,41). However, in regions where Ito is
poorly expressed (e.g., endocardium), the effects of INa and
ICa might be predominant, thus potentially leading to a
LQT3-like phenotype at slow heart rates (Fig. 10, B and C)
and BrS phenotype at high frequencies. In regions where Ito
is maximally expressed (e.g., epicardium), CaMKII activa-
tion or upregulation may lead to a markedly short AP, thus
resembling an acquired form of short QT syndrome. In fact,
although prolonged QT intervals are intuitively associated
with the risk of life-threatening events, the notion of a short
QT syndrome being arrhythmogenic is relatively new (42).
Heterogeneity of transmural ventricular repolarization in
the heart has been linked to a variety of arrhythmic
manifestations (43). If CaMKII prolongs APDs in the
endocardium (Fig. 10, B and C) and shortens APDs in the
epicardium (Fig. 10 A), this could amplify transmural
dispersion of repolarization (endo-epi 66 and 78 ms for
control versus 152 and 183 ms with CaMKII (Fig. 10)), thus
predisposing to the development of reentrant arrhythmias.
Thus, there are several potential pathways by which cardiac
CaMKII activation may be arrhythmogenic, and further ex-
perimental and in silico work will be needed to clarify which
pathways are most important.
Species differences and time domain of
CaMKII overexpression
In striking contrast to the AP shortening shown in rabbits, we
have shown that chronic CaMKII overexpression in mice
signiﬁcantly prolongs APD in transgenic versus wild-type
mice (7,15). Mouse electrophysiology differs signiﬁcantly
from that of rabbit, but this difference may be simply
explicable. In the mouse, with chronic overexpression of
CaMKII, INa and ICa are enhanced, as in rabbit, but Ito is
decreased. The result is that all three current changes
considered here will tend to prolong APD in mouse. Thus, it
is not surprising that CaMKII prolongs the APD in the
transgenic CaMKIIdc mouse (and differs from rabbit). In
rabbit myocytes, acute CaMKII overexpression increased Ito
mainly by increasing Ito recovery from inactivation for both
Ito,fast and Ito,slow (and this is an acute regulatory effect
sensitive to CaMKII inhibitors), but there is also a minor
increase in Ito,slow functional expression. In transgenic mice
chronically overexpressing CaMKIIdc, the same accelera-
tion of Ito recovery from inactivation occurs (acutely
blockable by CaMKII inhibition), but down-regulation of
Ito,fast (the predominant repolarizing current in mouse) and
Kv4.2/3 expression causes the dominant effect to be reduced
functional Ito (15). This raises the notion that CaMKII can
have both acute regulatory effects on ion channels (via
CaMKII-dependent phosphorylation), but can also alter the
expression levels (via CaMKII effects to alter protein
transcription, translation, or trafﬁcking (44)). There may
also be time-dependent differences in this regulation, since
24-h overexpression of CaMKII was sufﬁcient to demon-
strate upregulation of Ito,slow (and Kv1.4), whereas the
downregulation of Ito,fast was only evident during chronic
transgenic overexpression of CaMKII. Eventually, it would
be valuable to incorporate these longer-term aspects of chan-
nel modulation into dynamic computational models.
CaMKII modeling in cardiac myocytes
In our model, we simply turned on the CaMKII-modiﬁed
version of the modulated currents, without considering either
dynamic or local changes of its activity or association with
target ion channels. Recently, Hund and Rudy (45) proposed
a novel theoretical model of the canine ventricular epicardial
AP and Ca21 cycling, including a CaMKII regulatory path-
way. They investigated aspects of Ca21 transient and APD
rate dependence, and concluded that CaMKII is an important
determinant of the rate dependence of Ca21 transient but not
of APD (although neither INa or Ito were considered as
CaMKII targets). They also showed that elevated CaMKII
activity increased the cell propensity to Ca21 transient and
APD alternans (36).
Saucerman and Bers (2007) integrated mathematical
descriptions of calmodulin-dependent regulation of CaMKII
and calcineurin with the Chicago ECC model in the rabbit
ventricular myocyte (46). They showed how CaMKII is
especially well activated in regions where local [Ca21]i is
transiently high, especially in the junctional cleft near ICa and
SR Ca release sites. The subsarcolemmal region, where most
other ion channels (e.g., INa and Ito) are localized, also ex-
hibits higher [Ca21]i than bulk cytosolic [Ca
21]i (47) and
would thus also be expected to exhibit more dynamic
CaMKII activation.
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In conclusion, we present a computational modeling
approach to study how CaMKII-dependent changes in ionic
currents (INa, ICa, and Ito) inﬂuence APD at different heart
rates. This may provide novel mechanistic insights into
cellular bases of acquired arrhythmogenesis in HF and other
pathophysiological settings. It may also help to identify or
tailor novel potential therapeutic targets.
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